Marseille, France

Inaki Cervera-marzal

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique-Cnrs, Inserm (Institut National De La Santé Et De La Recherche Médicale), Université´ D'aix-Marseille. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inaki Cervera-marzal. Retrieved from https://idiyas.com/inventor/inaki-cervera-marzal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inaki Cervera-Marzal: Research and Patent Contribution

Introduction

Inaki Cervera-Marzal is an inventor based in Marseille, France. His patent work includes a method for analyzing the transcriptomes of selected B and T cell subsets.

Latest Patents

Cervera-Marzal is associated with 1 patent: “RNA Sequencing Method for the Analysis of B and T Cell Transcriptome in Phenotypically Defined B and T Cell Subsets.” The invention concerns RNA sequencing and the study of gene expression in phenotypically defined immune-cell populations.

Career Highlights

Cervera-Marzal has worked with Inserm (Institut National de la Santé et de la Recherche Médicale) and the French National Centre for Scientific Research (CNRS). His patent reflects research focused on methods for examining B and T cell transcriptomes.

Collaborations

His listed coworkers include Pierre Milpied and Noudjoud Attaf, who are associated with his research and patent work.

Conclusion

Inaki Cervera-Marzal’s recorded patent contribution centers on RNA sequencing methods for analyzing defined B and T cell subsets, alongside research affiliations with Inserm and CNRS.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…